• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

杂芳基取代的二氮杂螺环化合物作为支架的合成与评价,以探查蛋白激酶的 ATP 结合位点。

Synthesis and evaluation of heteroaryl substituted diazaspirocycles as scaffolds to probe the ATP-binding site of protein kinases.

机构信息

Cancer Research UK Cancer Therapeutics Unit, The Institute of Cancer Research, Sutton, UK.

出版信息

Bioorg Med Chem. 2013 Sep 15;21(18):5707-24. doi: 10.1016/j.bmc.2013.07.021. Epub 2013 Jul 19.

DOI:10.1016/j.bmc.2013.07.021
PMID:23920481
Abstract

With the success of protein kinase inhibitors as drugs to target cancer, there is a continued need for new kinase inhibitor scaffolds. We have investigated the synthesis and kinase inhibition of new heteroaryl-substituted diazaspirocyclic compounds that mimic ATP. Versatile syntheses of substituted diazaspirocycles through ring-closing metathesis were demonstrated. Diazaspirocycles directly linked to heteroaromatic hinge binder groups provided ligand efficient inhibitors of multiple kinases, suitable as starting points for further optimization. The binding modes of representative diazaspirocyclic motifs were confirmed by protein crystallography. Selectivity profiles were influenced by the hinge binder group and the interactions of basic nitrogen atoms in the scaffold with acidic side-chains of residues in the ATP pocket. The introduction of more complex substitution to the diazaspirocycles increased potency and varied the selectivity profiles of these initial hits through engagement of the P-loop and changes to the spirocycle conformation, demonstrating the potential of these core scaffolds for future application to kinase inhibitor discovery.

摘要

随着蛋白激酶抑制剂作为癌症治疗靶点的成功,人们对新的激酶抑制剂支架的需求持续存在。我们研究了新的杂芳基取代的二氮杂螺环化合物的合成和激酶抑制作用,这些化合物模拟了 ATP。通过闭环复分解反应展示了取代的二氮杂螺环的多功能合成。直接连接到杂芳环铰链结合基团的二氮杂螺环提供了多种激酶的有效配体抑制剂,可作为进一步优化的起点。通过蛋白质晶体学证实了代表性二氮杂螺环基序的结合模式。选择性特征受 hinge binder 基团和支架中碱性氮原子与 ATP 口袋中酸性侧链残基的相互作用的影响。在二氮杂螺环上引入更复杂的取代基,通过与 P 环的结合以及对螺环构象的改变,增加了这些初始命中物的效力,并改变了它们的选择性特征,这表明这些核心支架在未来激酶抑制剂发现方面具有应用潜力。

相似文献

1
Synthesis and evaluation of heteroaryl substituted diazaspirocycles as scaffolds to probe the ATP-binding site of protein kinases.杂芳基取代的二氮杂螺环化合物作为支架的合成与评价,以探查蛋白激酶的 ATP 结合位点。
Bioorg Med Chem. 2013 Sep 15;21(18):5707-24. doi: 10.1016/j.bmc.2013.07.021. Epub 2013 Jul 19.
2
Mutants of protein kinase A that mimic the ATP-binding site of protein kinase B (AKT).模拟蛋白激酶B(AKT)ATP结合位点的蛋白激酶A突变体。
J Mol Biol. 2003 Jun 20;329(5):1021-34. doi: 10.1016/s0022-2836(03)00518-7.
3
Crystal structures of catalytic subunit of cAMP-dependent protein kinase in complex with isoquinolinesulfonyl protein kinase inhibitors H7, H8, and H89. Structural implications for selectivity.环磷酸腺苷依赖性蛋白激酶催化亚基与异喹啉磺酰蛋白激酶抑制剂H7、H8和H89复合物的晶体结构。选择性的结构意义。
J Biol Chem. 1996 Oct 18;271(42):26157-64. doi: 10.1074/jbc.271.42.26157.
4
Drugging the Undruggable: How Isoquinolines and PKA Initiated the Era of Designed Protein Kinase Inhibitor Therapeutics.使不可成药者成药:异喹啉类化合物和蛋白激酶 A 如何开启设计的蛋白激酶抑制剂治疗学时代。
Biochemistry. 2021 Nov 23;60(46):3470-3484. doi: 10.1021/acs.biochem.1c00359. Epub 2021 Aug 9.
5
Discovery of spirocyclic sulfonamides as potent Akt inhibitors with exquisite selectivity against PKA.发现螺环磺酰胺类化合物作为强效 Akt 抑制剂,对 PKA 具有极高的选择性。
Bioorg Med Chem Lett. 2011 Apr 15;21(8):2335-40. doi: 10.1016/j.bmcl.2011.02.098. Epub 2011 Feb 26.
6
Autoregulation of kinase dephosphorylation by ATP binding in AGC protein kinases.AGC 蛋白激酶中 ATP 结合对激酶去磷酸化的自身调节。
Cell Cycle. 2012 Feb 1;11(3):475-8. doi: 10.4161/cc.11.3.19059.
7
Molecular Recognition of FDA-Approved Small Molecule Protein Kinase Drugs in Protein Kinases.在蛋白激酶中 FDA 批准的小分子蛋白激酶药物的分子识别。
Molecules. 2022 Oct 21;27(20):7124. doi: 10.3390/molecules27207124.
8
Design and crystal structures of protein kinase B-selective inhibitors in complex with protein kinase A and mutants.与蛋白激酶A及突变体复合的蛋白激酶B选择性抑制剂的设计与晶体结构
J Med Chem. 2005 Jan 13;48(1):163-70. doi: 10.1021/jm049701n.
9
Mutants of protein kinase A that mimic the ATP-binding site of Aurora kinase.模拟 Aurora 激酶 ATP 结合位点的蛋白激酶 A 突变体。
Biochem J. 2011 Nov 15;440(1):85-93. doi: 10.1042/BJ20110592.
10
Structure-based design of isoquinoline-5-sulfonamide inhibitors of protein kinase B.基于结构的蛋白激酶B的异喹啉-5-磺酰胺抑制剂设计
Bioorg Med Chem. 2006 Feb 15;14(4):1255-73. doi: 10.1016/j.bmc.2005.09.055. Epub 2005 Oct 24.

引用本文的文献

1
Palladium-Catalyzed Enantioselective Alkenylation of Enelactams Using a Relay Heck Strategy.使用接力Heck策略实现钯催化的烯内酰胺对映选择性烯基化反应。
Chemistry. 2019 Aug 14;25(46):10823-10827. doi: 10.1002/chem.201902813. Epub 2019 Jul 26.